We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+4.03%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$267M
AUM Growth
+$4.82M
Cap. Flow
-$9.92M
Cap. Flow %
-3.71%
Top 10 Hldgs %
58.34%
Holding
198
New
65
Increased
27
Reduced
24
Closed
58

Sector Composition

Rank Sector Weight
1 Healthcare 7.62%
2 Technology 3.66%
3 Financials 2.26%
4 Communication Services 2.2%
5 Energy 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
51
CALL
Goldman Sachs
GS
$300B
$756K 0.28%
3,000
GS icon
52
PUT
Goldman Sachs
GS
$300B
$756K 0.28%
3,000
DST
53
DELISTED
DST Systems Inc.
DST
$753K 0.28%
+9,000
New +$732K
MSCC
54
DELISTED
Microsemi Corp
MSCC
$751K 0.28%
+11,600
New +$717K
ZSAN
55
DELISTED
Zosano Pharma Corporation
ZSAN
$697K 0.26%
+3,951
New +$1.32M
FATE icon
56
Fate Therapeutics
FATE
$286M
$685K 0.26%
70,200
-20,923
-23% -$200K
NKE icon
57
PUT
Nike
NKE
$61.9B
$664K 0.25%
10,000
-5,000
-33% -$330K
JNJ icon
58
CALL
Johnson & Johnson
JNJ
$618B
$641K 0.24%
+5,000
New +$676K
JNJ icon
59
PUT
Johnson & Johnson
JNJ
$618B
$641K 0.24%
+5,000
New +$676K
MGI
60
DELISTED
MoneyGram International, Inc. New
MGI
$540K 0.2%
62,625
-51,012
-45% -$570K
PRTK
61
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$533K 0.2%
+40,977
New +$610K
ABBV icon
62
AbbVie
ABBV
$443B
$530K 0.2%
+5,597
New +$615K
VIRX
63
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$476K 0.18%
5,000
+622
+14% +$107K
CAVM
64
DELISTED
Cavium, Inc.
CAVM
$476K 0.18%
6,000
+1,000
+20% +$87.3K
AMRN
65
Amarin Corp
AMRN
$299M
$464K 0.17%
+7,700
New +$572K
SVU
66
CALL
DELISTED
SUPERVALU Inc.
SVU
$457K 0.17%
+30,000
New +$477K
NXTM
67
DELISTED
NxStage Medical Inc.
NXTM
$447K 0.17%
18,000
-4,000
-18% -$97.3K
RIGL icon
68
Rigel Pharmaceuticals
RIGL
$681M
$442K 0.17%
12,500
-11,490
-48% -$460K
ABLX
69
DELISTED
Ablynx NV
ABLX
$428K 0.16%
+7,836
New +$388K
D icon
70
Dominion Energy
D
$60.8B
$423K 0.16%
+6,272
New +$463K
BLPH
71
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$414K 0.16%
13,267
+7,972
+151% +$254K
ESRX
72
DELISTED
Express Scripts Holding Company
ESRX
$414K 0.16%
+6,000
New +$458K
ANET icon
73
Arista Networks
ANET
$227B
$378K 0.14%
+23,696
New +$399K
GLD icon
74
SPDR Gold Trust
GLD
$131B
$377K 0.14%
3,000
+600
+25% +$75.7K
ACHN
75
DELISTED
Achillion Pharmaceuticals
ACHN
$371K 0.14%
100,000
-35,000
-26% -$115K

Similar funds

Telemetry Investments's Q1 2018 Portfolio in Review

As of Q1 2018, Telemetry Investments held 198 positions worth $267M, up 1.8% from $262M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Telemetry Investments withdrew a net $9.92M in Q1 2018, closing 58 positions and reducing 24 holdings. Its most notable exit was Buffalo Wild Wings, Inc., an estimated $2.28M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 7.4% a quarter earlier, followed by Technology and Financials.

Against the trend, Telemetry Investments opened a new position in State Street SPDR S&P 500 ETF Trust worth $2.63M.

  • Telemetry Investments's largest Q1 2018 buy was State Street SPDR S&P 500 ETF Trust: 10,000 shares worth $2.63M.
  • Telemetry Investments added most to Aetna Inc in Q1 2018, an estimated $2.3M increase.
  • Telemetry Investments's biggest Q1 2018 reduction was Kadmon Holdings, Inc., cutting an estimated $2.91M.
  • Telemetry Investments fully exited Buffalo Wild Wings, Inc. in Q1 2018, selling an estimated $2.28M.
  • Telemetry Investments's ten largest holdings make up 58% of its $267M portfolio in Q1 2018.
  • Telemetry Investments opened 65 new positions and closed 58 in Q1 2018.
  • Telemetry Investments's portfolio value rose 1.8% quarter-over-quarter to $267M.

Based on Telemetry Investments's 13F filing for Q1 2018, filed 15 May 2018.